137 related articles for article (PubMed ID: 17405748)
1. Re-occurrence of the CD20 molecule expression subsequent to CD20-negative relapse in diffuse large B-cell lymphoma.
Ferreri AJ; Dognini GP; Verona C; Patriarca C; Doglioni C; Ponzoni M
Haematologica; 2007 Jan; 92(1):e1-2. PubMed ID: 17405748
[TBL] [Abstract][Full Text] [Related]
2. Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Hiraga J; Tomita A; Suzuki N; Takagi Y; Narita M; Kagami Y
Ann Hematol; 2018 Nov; 97(11):2253-2255. PubMed ID: 29725760
[No Abstract] [Full Text] [Related]
3. CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.
Johnson NA; Leach S; Woolcock B; deLeeuw RJ; Bashashati A; Sehn LH; Connors JM; Chhanabhai M; Brooks-Wilson A; Gascoyne RD
Haematologica; 2009 Mar; 94(3):423-7. PubMed ID: 19211644
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
5. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.
Johnson NA; Boyle M; Bashashati A; Leach S; Brooks-Wilson A; Sehn LH; Chhanabhai M; Brinkman RR; Connors JM; Weng AP; Gascoyne RD
Blood; 2009 Apr; 113(16):3773-80. PubMed ID: 19029441
[TBL] [Abstract][Full Text] [Related]
6. Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanism.
Walsh KJ; Al-Quran SZ; Li Y; Braylan RC; Lynch JW
Clin Lymphoma Myeloma; 2007 Jan; 7(4):319-22. PubMed ID: 17324342
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.
Micallef IN; Kirk A; Norton A; Foran JM; Rohatiner AZ; Lister TA
Blood; 1999 Apr; 93(7):2427-8. PubMed ID: 10215354
[No Abstract] [Full Text] [Related]
8. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D; Sebban C; Boulat O; Biron P; Rey J; Aurran T; Chabannon C; Xerri L; Chetaille B; Esterni B; Ivanov V; Stoppa AM; Schiano de Collela JM; Gastaut JA; Maraninchi D; Bouabdallah R
Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL; Stefoni V; Alinari L; Vianelli N; Baccarani M
Leuk Lymphoma; 2003 Sep; 44(9):1637-8. PubMed ID: 14565673
[No Abstract] [Full Text] [Related]
10. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
Kakinoki Y; Hashiguchi J; Ishio T; Chiba K; Niino D; Ohshima K
Int J Hematol; 2015 Dec; 102(6):702-8. PubMed ID: 26251099
[TBL] [Abstract][Full Text] [Related]
11. Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.
Sar A; Perizzolo M; Stewart D; Mansoor A; Difrancesco LM; Demetrick DJ
Leuk Res; 2009 Jun; 33(6):792-7. PubMed ID: 19054557
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone.
Chen YB; Hochberg EP; Feng Y; Neuberg D; Rawal B; Motyckova G; Fisher DC; McAfee SL; Spitzer TR; Lacasce AS
Leuk Lymphoma; 2010 May; 51(5):789-96. PubMed ID: 20367136
[TBL] [Abstract][Full Text] [Related]
13. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.
Rasheed AA; Samad A; Raheem A; Hirani SI; Shabbir- Moosajee M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):331-335. PubMed ID: 29479962
[TBL] [Abstract][Full Text] [Related]
14. Breast lymphoma.
Avilés A
Ann Oncol; 2008 Jul; 19(7):1360. PubMed ID: 18579558
[No Abstract] [Full Text] [Related]
15. Rituximab maintenance therapy in follicular lymphoma.
Forstpointner R; Dreyling M
Curr Hematol Malig Rep; 2007 Oct; 2(4):213-8. PubMed ID: 20425372
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a primary uterine B-cell lymphoma with rituximab-CHOP immunochemotherapy.
Egyed M; Kollár B; Prievara FT; Viski A; Bajzik G; Pajor L; Torday L
Haematologica; 2007 Feb; 92(2):e26-7. PubMed ID: 17405751
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.
Hiraga J; Tomita A; Sugimoto T; Shimada K; Ito M; Nakamura S; Kiyoi H; Kinoshita T; Naoe T
Blood; 2009 May; 113(20):4885-93. PubMed ID: 19246561
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Jorgensen JL; Cortes J; Faderl S; Garcia-Manero G; Verstovsek S; Koller C; Pierce S; Huh Y; Wierda W; Keating MJ; Kantarjian HM
Blood; 2009 Jun; 113(25):6330-7. PubMed ID: 18703706
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
Matsuda I; Hirota S
Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
[TBL] [Abstract][Full Text] [Related]
20. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
